Overview

Join this peer-led discussion to dive into the dosing, efficacy, and safety of a once-daily oral treatment option indicated for adult patients with obesity or with overweight in the presence of at least one weight-related comorbidity. Attendees will have the opportunity to ask questions at the conclusion of the program.

Program Objectives

- Summarize the safety and efficacy data for this treatment
- Identify appropriate adult patients
- Provide strategies for initiating and maintaining treatment

SPONSORED BY

Eli Lilly & Company